Navigation Links
Freeman elected to National Academy of Science
Date:5/2/2013

Katherine Haines Freeman, professor of geosciences, Penn State, has been elected to membership in the National Academy of Sciences for her excellence in original scientific research. Membership in the NAS is one of the highest honors given to a scientist or engineer in the United States.

Members of the National Academy, sometimes called "advisors to the nation," are charged with providing independent, objective advice on matters related to science and technology. Celebrating its 150th anniversary, the NAS was established in 1863 by President Abraham Lincoln and is dedicated to furthering science and technology for the good of the nation. Freeman joins 83 others elected this year, making the total NAS membership 2,179 U.S. and 437 foreign members.

Like a paleontologist, Freeman uses fossil biomolecules -- biomarkers -- and the stable isotopes of carbon and other elements to study ancient oceans, soils and lakes. She has used lipid and pigment biomarkers from algae, plants and microbes to study the links between water and carbon cycles and changes in climate over Earth's history. Her work shows that atmospheric carbon dioxide is high during periods of warm climate, plant ecosystems rapidly shift with changes in rain patterns and that global oxygen levels in the ocean impact and are impacted by microbial communities.

Freeman joined Penn State in 1991 as an assistant professor of geosciences and became an associate professor in 1997. In 2002, she was named professor of geosciences. She was associate head of geosciences from 2004 to 2009, and from 2003 to 2007, she directed the Penn State Biogeochemistry Research Initiative in Education, a National Science Foundation graduate training program. In 1997 she received the Peter Schenck Award from the European Association of Organic Geochemists, in 1999, the James Lee Wilson Medal in Sedimentology from the Society for Sedimentary Geology and, in 2012, she received the Science Innovation Award from the Euro
'/>"/>

Contact: A'ndrea Elyse Messer
aem1@psu.edu
814-865-9481
Penn State
Source:Eurekalert

Page: 1 2

Related biology news :

1. 3 NYU faculty elected to National Academy of Sciences
2. Carnegies Greg Asner elected to National Academy of Sciences
3. 87 scientists elected to the American Academy of Microbiology
4. Conference Programme Committees selected for the 20th International AIDS Conference (AIDS 2014)
5. Desert Research Institute scientist selected to help guide next USGS, NASA Landsat Mission
6. BONESUPPORT Selected As A 2012 Red Herring Top 100 Global
7. UMass Medical School faculty elected to the American Association for the Advancement of Science
8. 34 ASPB members elected to 2012 class of AAAS Fellows
9. The IPCC Report on Climate Change - Swedish professor Thomas Sterner selected as 1 of the experts
10. Aware Announces Closing Of Sale Of Selected Patents
11. Aware Announces Sale of Selected Patents
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/18/2014)... The ability to acquire and creatively manipulate spoken language ... over the past 6 million years of human evolution ... is the best candidate gene we now have," says ... LMU. In his efforts to understand the molecular biological ... step forward. The results of his latest study, undertaken ...
(Date:9/18/2014)... across racial and ethnic groups describe losing eyesight ... day-to-day life, more so than other conditions including: ... of African-Americans, 49% of non-Hispanic whites, 43% of ... disease or ailment is the worst that could ... followed by AIDS/HIV. Hispanics and Asians ranked ...
(Date:9/18/2014)... and nitrogen comprise all spheres of our planet. ... caused imbalances and perturbations that resulted in increases ... result in climate changes which influence the complex ... atmosphere. Understanding these feedback mechanisms has become an ... during the past three decades. , In parallel, ...
Breaking Biology News(10 mins):Language evolution: Quicker on the uptake 2Language evolution: Quicker on the uptake 3Americans rate losing eyesight as having greatest impact on their lives 2Americans rate losing eyesight as having greatest impact on their lives 3Greenhouse gas research enters a new era 2
... at the University of California, San Francisco (UCSF) has ... to a common but untreatable and incurable neurodegenerative disease. ... common cause of dementia before age 65, after Alzheimer,s ... the UCSF team,s work explains in part why the ...
... available in French . The Universit ... of the Botanical Garden. The new Centre, the result of ... the Montral Insectarium, two Espace pour la vie (Montral Space ... biodiversity, its preservation and its promotion. The Centre will not ...
... LA LSU oncologist Vince D. Cataldo, MD, is ... chemotherapy drugs now indicated for second and third-line therapy ... effective in treating a certain subset of these patients. ... LSU Health Sciences Center New Orleans School of Medicine, ...
Cached Biology News:UCSF report describes new model for neurodegeneration 2UCSF report describes new model for neurodegeneration 3The University of Montreal Biodiversity Centre opens 2The University of Montreal Biodiversity Centre opens 3Study shows new treatment strategy effective for certain lung cancers 2
(Date:9/19/2014)... , September 19, 2014 BioTech ... developments, patents and results of studies and trials.  Companies ... and Company (NYSE: LLY ), Gilead Sciences ... CELG ) and Arena Pharmaceuticals Inc. (NASDAQ: ... in developing prodrug therapeutics for the treatment of cancer, ...
(Date:9/19/2014)... The new , Healthcare and Life Sciences Review , ... PharmaBoardroom.com for free download , looks beyond the ... in 2009, and the austerity measures that followed, to find ... of trouble. "Despite the crisis, Spain ... the general conditions to invest are favorable to the pharmaceutical ...
(Date:9/18/2014)... (PRWEB) September 18, 2014 A novel ... an MRI scanner is currently being tested as part ... Women's Hospital in Boston with the aim of determining ... can make prostate cancer biopsies faster, more accurate, less ... system also has the potential to deliver prostate cancer ...
(Date:9/18/2014)... Sept. 18, 2014 Research and Markets ... and Chinese Stem Cell Industry Report, 2014-2017" report ... undifferentiated biological cells that can differentiate into specialized cells ... cells. Stem cell therapy can be applied to treatment ... disease), nervous system diseases, damage or lesion of liver, ...
Breaking Biology Technology:Biotech Companies Pushing Sector Higher With Recent Therapeutic Advancements & Patent Approvals - Company Wins Summary Judgment For Prodrug Patent 2Biotech Companies Pushing Sector Higher With Recent Therapeutic Advancements & Patent Approvals - Company Wins Summary Judgment For Prodrug Patent 3Biotech Companies Pushing Sector Higher With Recent Therapeutic Advancements & Patent Approvals - Company Wins Summary Judgment For Prodrug Patent 4Biotech Companies Pushing Sector Higher With Recent Therapeutic Advancements & Patent Approvals - Company Wins Summary Judgment For Prodrug Patent 5Biotech Companies Pushing Sector Higher With Recent Therapeutic Advancements & Patent Approvals - Company Wins Summary Judgment For Prodrug Patent 6Biotech Companies Pushing Sector Higher With Recent Therapeutic Advancements & Patent Approvals - Company Wins Summary Judgment For Prodrug Patent 7PharmaBoardroom Releases New Spain Pharmaceuticals Report 2PharmaBoardroom Releases New Spain Pharmaceuticals Report 3Worcester Polytechnic Institute Participates in Clinical Trial for MRI-Compatible Robot Designed to Improve Accuracy of Prostate Cancer Biopsies 2Worcester Polytechnic Institute Participates in Clinical Trial for MRI-Compatible Robot Designed to Improve Accuracy of Prostate Cancer Biopsies 3Worcester Polytechnic Institute Participates in Clinical Trial for MRI-Compatible Robot Designed to Improve Accuracy of Prostate Cancer Biopsies 4Worcester Polytechnic Institute Participates in Clinical Trial for MRI-Compatible Robot Designed to Improve Accuracy of Prostate Cancer Biopsies 5Worcester Polytechnic Institute Participates in Clinical Trial for MRI-Compatible Robot Designed to Improve Accuracy of Prostate Cancer Biopsies 6Global and Chinese Stem Cell Industry Report, 2014-2017 2Global and Chinese Stem Cell Industry Report, 2014-2017 3
... First Clinical Milestone Validates Approach, SAN FRANCISCO, ... completion of its first clinical trial, a,proof-of-concept study ... sodium channel blocker. Rufinamide was discovered and,developed by ... Europe as a,drug to treat a form of ...
... January 22 Progentix,Orthobiology B.V. announced today the ... was led by BioGeneration Ventures., Progentix Orthobiology ... suite of osteoinductive material products for clinical application,in ... based on,surface structured ceramic biomaterial scaffolds that have ...
... year the NorTech Venture,Capital Advisory Task Force reported in ... need to generate and attract over $1.2 billion,in venture ... needs of companies,located in Northeast Ohio. According to the ... the Cleveland+ region, to be,released in print mid February, ...
Cached Biology Technology:Synosia Announces Encouraging Results of Proof-of-Concept Clinical Trial for Epilepsy Drug rufinamide as a Treatment for Mood Disorders 2Synosia Announces Encouraging Results of Proof-of-Concept Clinical Trial for Epilepsy Drug rufinamide as a Treatment for Mood Disorders 3Progentix Orthobiology B.V. Closes Series A Financing Round 2Cleveland+ Region Attracts $318 Million in New Venture Investment in 2007 2Cleveland+ Region Attracts $318 Million in New Venture Investment in 2007 3Cleveland+ Region Attracts $318 Million in New Venture Investment in 2007 4Cleveland+ Region Attracts $318 Million in New Venture Investment in 2007 5
Mouse polyclonal antibody raised against a partial recombinant DDEF2. NCBI Entrez Gene ID = 8853...
Mouse monoclonal antibody raised against a full length recombinant SCGB3A2. NCBI Entrez Gene ID = SCGB3A2...
Mouse monoclonal antibody raised against a partial recombinant QARS. NCBI Entrez Gene ID = QARS...
Mouse polyclonal antibody raised against a partial recombinant QPCT. NCBI Entrez Gene ID = 25797...
Biology Products: